Cargando…
Multi-omics analysis identifies RFX7 targets involved in tumor suppression and neuronal processes
Recurrently mutated in lymphoid neoplasms, the transcription factor RFX7 is emerging as a tumor suppressor. Previous reports suggested that RFX7 may also have a role in neurological and metabolic disorders. We recently reported that RFX7 responds to p53 signaling and cellular stress. Furthermore, we...
Autores principales: | Schwab, Katjana, Coronel, Luis, Riege, Konstantin, Sacramento, Erika K., Rahnis, Norman, Häckes, David, Cirri, Emilio, Groth, Marco, Hoffmann, Steve, Fischer, Martin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9981735/ https://www.ncbi.nlm.nih.gov/pubmed/36864036 http://dx.doi.org/10.1038/s41420-023-01378-1 |
Ejemplares similares
-
p53-mediated AKT and mTOR inhibition requires RFX7 and DDIT4 and depends on nutrient abundance
por: Coronel, Luis, et al.
Publicado: (2021) -
Transcription factor RFX7 governs a tumor suppressor network in response to p53 and stress
por: Coronel, Luis, et al.
Publicado: (2021) -
QRFXFreeze: Queryable Compressor for RFX
por: Senthilkumar, Radha, et al.
Publicado: (2015) -
Molecular characterization of hematopoietic stem cells after in vitro amplification on biomimetic 3D PDMS cell culture scaffolds
por: Marx-Blümel, Lisa, et al.
Publicado: (2021) -
The landscape of human p53‐regulated long non‐coding RNAs reveals critical host gene co‐regulation
por: Fischer, Martin, et al.
Publicado: (2023)